![Erik Akhund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erik Akhund
Corporate Officer/Principal presso Quadrant Capital Advisors, Inc.
Profilo
Erik Akhund is currently a Managing Director at Quadrant Capital Advisors, Inc. He was previously a Director at Melinta Subsidiary Corp.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York and an MBA from INSEAD.
Posizioni attive di Erik Akhund
Società | Posizione | Inizio |
---|---|---|
Quadrant Capital Advisors, Inc.
![]() Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Precedenti posizioni note di Erik Akhund
Società | Posizione | Fine |
---|---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Direttore/Membro del Consiglio | - |
Formazione di Erik Akhund
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
INSEAD | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Melinta Subsidiary Corp.
![]() Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Quadrant Capital Advisors, Inc.
![]() Quadrant Capital Advisors, Inc. Investment ManagersFinance Quadrant Capital Advisors, Inc. provides investment advisory services. The company was founded on March 04, 2003 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Erik Akhund